No fee unless we recover compensation for your family Text size 833-4-ASBESTOS (833-427-2378) Free Case Review

Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients

Our plain-English summary of Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients, by M. Maeda, Y. Nishimura, H. Hayashi, et al (American Journal of Respiratory Cell and Molecular Biology, 2011).

You don't need the product names or old records. No fee unless we recover compensation for your family.

Call 833-4-ASBESTOS Request a review

The study

Abstract

Asbestos causes malignant tumors such as lung cancer and malignant mesothelioma (MM). To determine whether asbestos exposure causes reduction of antitumor immunity, we established an in vitro T-cell line model of low-dose and continuous exposure to asbestos using an human adult T-cell leukemia virus-1 immortalized human polyclonal T-cell line, MT-2, and revealed that MT-2 cells exposed continuously to asbestos showed resistance to asbestos-induced apoptosis. In addition, the cells presented reduction of surface CXCR3 chemokine receptor expression and IFN-γ production. In this study, to confirm that these findings are suitable for clinical translation, surface CXCR3 and IFN-γ expression were analyzed using freshly isolated human CD4(+) T cells derived from healthy donors and patients with pleural plaque (PP) or MM. The results revealed that CXCR3 and IFN-γ expression in the ex vivo model were reduced in some cases. Additionally, CXCR3 expression in CD4(+) T cells from PPs and MMs was significantly reduced compared with that from healthy donors, and CD4(+) T cells from patients with MMs exhibited a marked reduction in IFN-γ mRNA levels after stimulation in vitro. Moreover, CD4(+)CXCR3(+) T cells in lymphocytes from MMs showed a tendency for an inverse correlation with its ligand CXCL10/IP10 in plasma. These findings show reduction of antitumor immune function in asbestos-exposed patients and indicate that CXCR3, IFN-γ, and CXCL10/IP10 may be candidates to detect and monitor disease status.

In plain English

This Japanese laboratory study combined an ex vivo chrysotile experiment with blood analyses from asbestos-exposed patients. Stimulated CD4+ T cells from healthy donors were cultured with chrysotile-B at doses printed as 2 to 10 mg/cm2. In a representative example, surface CXCR3 fell with increasing dose after 40 days. Across six donors at 10 mg/cm2, CXCR3 was significantly reduced at 28 days, though the authors noted this depended largely on one case; CCR5 showed no significant change. In three donors whose CXCR3 had fallen, IFN-gamma mRNA (P = 0.3226) and IFN-gamma-positive cells (P = 0.0511) fell or tended to fall, neither significantly. In 19 healthy donors, 13 pleural plaque patients and 8 malignant mesothelioma patients, CXCR3 on CD4+ T cells was significantly lower in both patient groups; CCR5 did not differ. The patient groups were older (mean 71.5 and 67.4 years versus 42.3); 13 younger and 6 older healthy donors did not differ significantly in CXCR3. In stimulated CD4+ T cells, IFN-gamma mRNA was significantly reduced only in mesothelioma, and IL-6 in culture supernatants was higher in both patient groups.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

  • Design: Laboratory study: ex vivo culture experiment on human CD4+ T cells exposed to chrysotile, plus cross-sectional comparison of blood samples from healthy donors and patients with pleural plaque or malignant mesothelioma
  • Who was studied: Ex vivo experiment: CD4+ T cells from 6 healthy donors (mean age 34.8, range 25-50; 3 men, 3 women). Patient analysis: 19 healthy donors (mean age 42.3), 13 patients with pleural plaque (mean age 71.5), 8 with malignant mesothelioma (mean age 67.4); mRNA and cytokine analyses in 13 healthy donors, 13 pleural plaque, 7 mesothelioma; plasma CXCL10 in 10, 8 and 8. Kawasaki Medical School and Okayama Rosai Hospital, Japan.
  • Exposure: In culture: chrysotile-B at doses printed as 2 to 10 mg/cm2 (the six-donor comparison used 10 mg/cm2 for 7 and 28 days; a representative dose-response example ran 40 days). In patients: past asbestos exposure, as indicated by pleural plaque or malignant mesothelioma.
  • Main results:
    • In a representative example of cultured CD4+ T cells from a healthy donor, surface CXCR3 decreased with increasing chrysotile-B dose (2 to 10 mg/cm2 as printed) after 40 days
    • The comparison across all six healthy donors used 10 mg/cm2 chrysotile-B for 7 and 28 days
    • Across the six donors, CXCR3 was significantly reduced after 28 days at 10 mg/cm2, but the authors noted the difference appeared to depend on one case
    • CCR5 expression in cultured CD4+ T cells varied among donors and showed no significant change after 7 or 28 days of chrysotile-B exposure
    • The IFN-gamma analysis used donors who had shown decreased surface CXCR3 after chrysotile-B exposure
    • In these three donors, IFN-gamma mRNA fell in all three after 28 days of exposure without statistical significance (P = 0.3226), and IFN-gamma-positive cells tended to fall (P = 0.0511)
    • In patients, the percentage of CD4+CXCR3+ T cells in lymphocytes was significantly lower in pleural plaque and mesothelioma than in healthy donors, with mesothelioma lowest; CD4+CCR5+ percentages did not differ
    • CXCR3 expression in CD4+ T cells was significantly lower in pleural plaque and mesothelioma patients than in healthy donors; CCR5 expression did not differ
    • Among healthy donors, younger (n = 13) and older (n = 6) groups did not differ significantly in CD4+CXCR3+ percentage or CXCR3 expression
    • IFN-gamma mRNA in stimulated CD4+ T cells was significantly decreased only in the mesothelioma group compared with healthy donors and pleural plaque
    • No significant correlation was found between CXCR3 expression and IFN-gamma mRNA in any of the three groups
    • Secreted IFN-gamma in supernatants from cultured CD4+ T cells did not differ significantly between groups
    • In supernatants from cultured, stimulated CD4+ T cells, IL-6 was significantly higher in pleural plaque and mesothelioma than in healthy donors
    • Plasma CXCL10/IP10 tended to be higher in pleural plaque and mesothelioma than in healthy donors, without significant difference
    • Correlation between CD4+CXCR3+ percentage and plasma CXCL10/IP10 was not significant in any group, with an inverse tendency in mesothelioma (P = 0.081)
  • The authors' conclusion: The authors concluded that reduction of CXCR3 expression in human peripheral CD4+ T cells occurred after chronic chrysotile exposure, suggesting antitumour immunity might not function normally in patients with asbestos-related disease, and that IFN-gamma suppression appeared linked to the occurrence of mesothelioma rather than to asbestos exposure itself.
  • Limitations the authors state:
    • The ex vivo model could not reproduce months-long exposure because IL-2-dependent proliferation of CD4+ T cells is not permanent, limiting culture to several weeks
    • The number of cases used in the ex vivo intracellular IFN-gamma experiment was small
    • The significant CXCR3 reduction at 28 days appeared to be driven by one case
    • The authors noted the significantly higher IL-4 concentration in mesothelioma might be too low to have physiological function

Topics

The National Library of Medicine indexes this study under subjects our site covers: Asbestosis, Chrysotile, Lung cancer, Mesothelioma.

Medical terms in this study, explained in our Lexicon: Lung Cancer, Malignant Mesothelioma, Asbestos Exposure, Apoptosis, Pleural Plaques.

Browse more research in American Journal of Respiratory Cell and Molecular Biology, or return to medical research.

Cited on this site

How to cite it

Cite the study

M. Maeda, Y. Nishimura, H. Hayashi, N. Kumagai, Y. Chen, S. Murakami, et al. Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients. American Journal of Respiratory Cell and Molecular Biology 2011;45(4):795-803. doi:10.1165/rcmb.2010-0435OC. PMID: 21357438.

Cite our summary

“Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/decreased-cxcr3-expression-in-cd4-t-cells-exposed-to-asbestos-or.

ACL Doc numbers and their short links never change. See how to cite the Library.

Talk with an asbestos lawyer

Start with what you remember, and we'll take it from there.

This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.